LLY

1,084.9

+1%↑

JNJ

231.61

+0.29%↑

ABBV

214.93

+1.26%↑

UNH

381.61

+0.56%↑

AZN

186.94

-0.13%↓

LLY

1,084.9

+1%↑

JNJ

231.61

+0.29%↑

ABBV

214.93

+1.26%↑

UNH

381.61

+0.56%↑

AZN

186.94

-0.13%↓

LLY

1,084.9

+1%↑

JNJ

231.61

+0.29%↑

ABBV

214.93

+1.26%↑

UNH

381.61

+0.56%↑

AZN

186.94

-0.13%↓

LLY

1,084.9

+1%↑

JNJ

231.61

+0.29%↑

ABBV

214.93

+1.26%↑

UNH

381.61

+0.56%↑

AZN

186.94

-0.13%↓

LLY

1,084.9

+1%↑

JNJ

231.61

+0.29%↑

ABBV

214.93

+1.26%↑

UNH

381.61

+0.56%↑

AZN

186.94

-0.13%↓

Home・Stock List・10X Genomics Inc (Class A)

10X Genomics Inc (Class A)

Closed

SectorHealthcare

24.58 4.11

Buy Sell

Overview

Share price change

24h

Current

Min

23.51

Max

24.94

Key metrics
By Trading Economics
Income	2.8M -13M
Sales	-15M 151M
EPS	0.072
Profit margin	-8.93
Employees	1,178
EBITDA	2.5M -17M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+3.72% upside

Dividends
By Dow Jones
Next Earnings	6 Aug 2026

Market Stats
By TradingEconomics
Market Cap	-69M 2.7B
Previous open	20.47
Previous close	24.58

News Sentiment

By Acuity

50%

154 / 344 Healthcare

10X Genomics Inc (Class A) Chart

Past performance is not a reliable indicator of future results.

Related News

26 May 2026, 16:52 UTC

Major News Events

NYMEX Overview: Brent Crude Futures Up; Iran Warns of Retaliation After US Strike -- OPIS

26 May 2026, 23:57 UTC

Earnings

Sociedad Quimica 1Q Rev $1.76B >SQM

26 May 2026, 23:57 UTC

Earnings

Sociedad Quimica 1Q EPS $1.28 >SQM

26 May 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Continued AI Enthusiasm -- Market Talk

26 May 2026, 21:54 UTC

Earnings

Webco Industries 3Q EPS $11.61 >WEBC

26 May 2026, 21:54 UTC

Earnings

Webco Industries 3Q Sales $179.6M >WEBC

26 May 2026, 21:48 UTC

Market Talk

GE Aerospace's Repair Boom Should Last for Years -- Market Talk

26 May 2026, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

26 May 2026, 20:58 UTC

Acquisitions, Mergers, Takeovers

Uber's $11.6 Billion Bid for DoorDash Rival Is About Future Proofing It From Robots -- Barrons.com

26 May 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

26 May 2026, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

26 May 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

26 May 2026, 19:22 UTC

Market Talk

Cryptocurrencies Add to Losses in Afternoon Trading -- Market Talk

26 May 2026, 19:17 UTC

Market Talk

Oil Recovers Some Losses on U.S.-Iran Skirmishes -- Market Talk

26 May 2026, 18:56 UTC

Market Talk

U.S. Natural Gas Futures Slip in Rangebound Trading -- Market Talk

26 May 2026, 18:03 UTC

Market Talk

AutoCanada Faces Soft Demand, Slow Normalization -- Market Talk

26 May 2026, 17:42 UTC

Market Talk

Grains Await Fresh Trading Catalyst -- Market Talk

26 May 2026, 17:33 UTC

Market Talk

Salesforce, Snowflake Could Dispel Software Bear Thesis -- Market Talk

26 May 2026, 17:21 UTC

Market Talk

Canada Faces a Labor Market Squeeze -- Market Talk

26 May 2026, 16:52 UTC

Market Talk

Bonds to Fund Infrastructure for Data Centers Could Be Risky -- Market Talk

26 May 2026, 16:43 UTC

Market Talk

Spotify's Latest Audio Play: Magazine Articles -- Market Talk

26 May 2026, 16:24 UTC

Market Talk

Dollarama's LATAM Slowdown, Australia Costs Seen as Transient -- Market Talk

26 May 2026, 16:21 UTC

Market Talk

Oil Extends Gains As Strikes Add Tension to U.S.-Iran Talks -- Market Talk

26 May 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

26 May 2026, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

26 May 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

26 May 2026, 16:20 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Auto & Transport Roundup: Market Talk

26 May 2026, 16:16 UTC

Market Talk

Alberta Separation Threat Poses Headwind for Canada Dollar -- Market Talk

26 May 2026, 16:01 UTC

Market Talk

Bitcoin Lower as Stress Builds for Holders -- Market Talk

26 May 2026, 15:21 UTC

Market Talk

Hyperliquid Pushes Up to New All-Time High -- Market Talk

Peer Comparison

Price change

10X Genomics Inc (Class A) Forecast

Price Target

By TipRanks

3.72% upside

12 Months Forecast

Average 24.56 USD 3.72%

High 32 USD

Low 20 USD

Based on 11 Wall Street analysts offering 12 month price targets for10X Genomics Inc (Class A) - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

Buy

Hold

Sell

Based on 11 analysts giving stock ratings to 10X Genomics Inc (Class A) - Dist in the past 3 months.

Sentiment

By Acuity

154 / 344 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.